Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (301-310 of 457) with videos related to

Pageof 46
Sort By:
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Leukemia Research|August 18, 2018
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)Joshua F Zeidner, Matthew C Foster, Amanda L Blackford, et al.
British Journal of Haematology|March 5, 2020
Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)Guadalupe Antelo, Abhishek A Mangaonkar, Giacomo Coltro, et al.
Genetic Testing and Molecular Biomarkers|February 12, 2015
Relationship of genetic variation in the serotonin transporter gene (SLC6A4) and congenital and acquired cardiovascular diseasesAnn M Moyer, Denise L Walker, Rajeswari Avula, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failureMichel Duval, John P Klein, Wensheng He, et al.
Blood Advances|May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomabTalha Badar, Aniko Szabo, Anjali Advani, et al.
Blood|February 27, 2009
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993Adele K Fielding, Jacob M Rowe, Susan M Richards, et al.
Plos One|March 30, 2021
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic reviewYaping Chang, Gordon H Guyatt, Trevor Teich, et al.
Transplantation and Cellular Therapy|April 10, 2021
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe StudyMatthew D Seftel, Pintip Chitphakdithai, John P Miller, et al.
British Journal of Haematology|March 29, 2020
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trialChezi Ganzel, Xin V Wang, Jacob M Rowe, et al.
Pageof 46

Showing results (301-310 of 457) with videos related to

Sort By:
Pageof 46
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Leukemia Research|August 18, 2018
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)Joshua F Zeidner, Matthew C Foster, Amanda L Blackford, et al.
British Journal of Haematology|March 5, 2020
Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)Guadalupe Antelo, Abhishek A Mangaonkar, Giacomo Coltro, et al.
Genetic Testing and Molecular Biomarkers|February 12, 2015
Relationship of genetic variation in the serotonin transporter gene (SLC6A4) and congenital and acquired cardiovascular diseasesAnn M Moyer, Denise L Walker, Rajeswari Avula, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failureMichel Duval, John P Klein, Wensheng He, et al.
Blood Advances|May 27, 2020
Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomabTalha Badar, Aniko Szabo, Anjali Advani, et al.
Blood|February 27, 2009
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993Adele K Fielding, Jacob M Rowe, Susan M Richards, et al.
Plos One|March 30, 2021
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic reviewYaping Chang, Gordon H Guyatt, Trevor Teich, et al.
Transplantation and Cellular Therapy|April 10, 2021
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe StudyMatthew D Seftel, Pintip Chitphakdithai, John P Miller, et al.
British Journal of Haematology|March 29, 2020
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trialChezi Ganzel, Xin V Wang, Jacob M Rowe, et al.
Pageof 46